The management of axillary lymph nodes in breast cancer is continually evolving. Recent data now support omitting axillary lymph node dissection (ALND) in most patients with metastases in up to two ...

This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.

Triple-negative breast cancer is fast-growing and challenging, but doctors highlight Mary Vasanthi’s journey as proof that hope and recovery are possible.